- Report
- April 2022
- 40 Pages
South Korea
From €1481EUR$1,500USD£1,233GBP
- Report
- April 2022
- 40 Pages
United States
From €1481EUR$1,500USD£1,233GBP
- Report
- April 2022
- 40 Pages
Vietnam
From €1481EUR$1,500USD£1,233GBP
- Report
- March 2022
- 100 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- February 2022
- 100 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- February 2022
- 40 Pages
India
From €1481EUR$1,500USD£1,233GBP
- Report
- February 2022
- 40 Pages
Saudi Arabia
From €1481EUR$1,500USD£1,233GBP
- Report
- January 2022
- 40 Pages
India
From €1481EUR$1,500USD£1,233GBP
- Report
- January 2022
- 40 Pages
Saudi Arabia
From €1481EUR$1,500USD£1,233GBP
- Report
- March 2020
- 40 Pages
Saudi Arabia
From €1481EUR$1,500USD£1,233GBP
- Report
- February 2020
- 100 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- July 2024
- 268 Pages
China
From €3951EUR$4,000USD£3,287GBP
- Report
- July 2024
- 78 Pages
China
From €1778EUR$1,800USD£1,479GBP
- Report
- July 2024
- 141 Pages
China
From €1778EUR$1,800USD£1,479GBP
- Report
- November 2023
- 54 Pages
China
From €1778EUR$1,800USD£1,479GBP
- Report
- November 2023
- 230 Pages
China
From €3951EUR$4,000USD£3,287GBP
- Report
- November 2023
- 86 Pages
China
From €1778EUR$1,800USD£1,479GBP
- Report
- October 2023
- 25 Pages
Global
€12099EUR$12,250USD£10,066GBP
- Report
- October 2023
- 26 Pages
Global
€12099EUR$12,250USD£10,066GBP
- Report
- January 2023
- 50 Pages
United States
From €2963EUR$3,000USD£2,465GBP
The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more